“According to a new report published by Introspective Market Research, Blood and Blood Components Market by Product Type, Application, and End User, The Global Blood and Blood Components Market Size Was Valued at USD 13.72 Billion in 2023 and is Projected to Reach USD 18.60 Billion by 2032, Growing at a CAGR of 3.44% from 2024 to 2032.”

The Blood and Blood Components Market plays a critical role in modern healthcare, supporting a wide range of medical procedures including surgeries, trauma care, cancer treatment, organ transplants, and the management of chronic blood disorders. Blood components such as red blood cells, platelets, plasma, and cryoprecipitate are separated and used based on specific patient requirements, improving treatment efficiency and safety.

Advancements in blood collection, storage, and screening technologies have significantly enhanced transfusion safety and availability. Compared to whole blood transfusions, component-based transfusions reduce wastage, improve clinical outcomes, and allow targeted therapy. The increasing number of surgical procedures, rising incidence of hematological disorders, and growing awareness regarding voluntary blood donation continue to support market expansion.

Furthermore, government initiatives, improved healthcare infrastructure, and expanding access to transfusion services in developing economies are strengthening the global blood supply chain. As healthcare systems focus on patient safety and efficient resource utilization, demand for blood components is expected to grow steadily over the forecast period.

Market Segmentation

The Blood and Blood Components Market is segmented into Product Type, Application, and End User.
By Product Type, the market is categorized into Red Blood Cells, Platelets, Plasma, and Others.
By Application, the market is categorized into Surgery, Trauma Care, Oncology, Hematological Disorders, and Others.
By End User, the market is categorized into Hospitals, Blood Banks, Diagnostic Centers, and Others.

Growth Driver

The rising prevalence of chronic diseases and surgical interventions is a key growth driver for the Blood and Blood Components Market. Conditions such as cancer, anemia, hemophilia, and cardiovascular disorders often require repeated blood transfusions. Additionally, the global increase in road accidents and trauma cases has significantly boosted the demand for blood components, especially red blood cells and plasma. Growing geriatric populations, who are more susceptible to surgical procedures and chronic illnesses, further contribute to sustained demand, supporting steady market growth across both developed and emerging healthcare systems.

Market Opportunity

Expanding healthcare infrastructure and increasing awareness of voluntary blood donation present significant growth opportunities for the market. Governments and healthcare organizations are investing in modern blood banks, advanced screening technologies, and digital donor management systems to improve blood availability and safety. Emerging economies, particularly in Asia-Pacific, Latin America, and the Middle East, offer untapped potential due to improving medical facilities and rising healthcare spending. Technological advancements in pathogen reduction and storage solutions are also expected to create new opportunities for market players.

Detailed Segmentation

The Blood and Blood Components Market is segmented on the basis of Product Type, Application, and End User.

Product Type
The Product Type segment is further classified into Red Blood Cells, Platelets, and Plasma. Among these, the Red Blood Cells sub-segment accounted for the highest market share in 2023. Red blood cells are the most commonly transfused component due to their critical role in oxygen delivery and their widespread use in surgeries, trauma cases, and anemia treatment. The consistent demand for red blood cell transfusions across hospitals and emergency care settings continues to drive dominance of this segment.

Application
The Application segment is further classified into Surgery, Trauma Care, and Oncology. Among these, the Surgery sub-segment accounted for the highest market share in 2023. Surgical procedures often require preoperative and postoperative blood transfusions, particularly in orthopedic, cardiovascular, and organ transplant surgeries. The growing number of elective and emergency surgical procedures worldwide has significantly contributed to the strong demand for blood components in this segment.

Some of The Leading/Active Market Players Are-

• American Red Cross (U.S.)
• CSL Behring (Australia)
• Grifols S.A. (Spain)
• Octapharma AG (Switzerland)
• Fresenius Kabi (Germany)
• Sanquin (Netherlands)
• Terumo Corporation (Japan)
• Japan Red Cross Society (Japan)
• HemaCare Corporation (U.S.)
• Macopharma (France)
• China Biologic Products Holdings, Inc. (China)
• Kedrion Biopharma (Italy)
• LFB Group (France)
• New York Blood Center (U.S.)
• Bio Products Laboratory (UK)
and other active players.

Key Industry Developments

In March 2024, a leading blood services organization expanded its plasma collection capacity to address rising global demand.
The expansion included the establishment of new plasma donation centers and upgraded processing facilities, aimed at improving plasma availability for therapeutic use and strengthening supply chain resilience.

In July 2023, a major healthcare company introduced advanced pathogen-reduction technology for blood components.
This innovation enhanced transfusion safety by reducing the risk of transfusion-transmitted infections, supporting higher adoption rates among hospitals and blood banks worldwide.

Key Findings of the Study

• Red blood cells remain the dominant product segment globally
• Hospitals account for the largest end-user share
• North America leads the market due to advanced healthcare infrastructure
• Rising surgical procedures and trauma cases drive market growth
• Technological advancements improve blood safety and storage

More Info:- http://introspectivemarketresearch.com/reports/blood-and-blood-components-market/

About Us

At Introspective Market Research Private Limited, we are a forward-thinking research consulting firm committed to driving growth in the Blood and Blood Components Market. With deep insights, strategic solutions, and holistic research, we empower businesses to achieve success and dominance in the global healthcare industry.

📞 Contact Us
Introspective Market Research Pvt. Ltd.
Phone: +91-91753-37569
Email: sales@introspectivemarketresearch.com
Web: www.introspectivemarketresearch.com